Position in PTCT
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$35,087,017
-$1,289,998 QoQ
Shares Held
515,001
+7.5% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. PTCT ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in PTCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,087,017 | 515,001 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $36,377,015 | 478,897 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,153,336 | 67,677 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,637,359 | 54,000 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $297,606 | 5,840 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $268,808 | 5,955 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $247,679 | 6,676 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $376,805 | 12,322 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $516,754 | 17,764 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $481,583 | 17,474 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $394,953 | 17,624 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $703,631 | 17,301 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $864,992 | 17,857 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $689,693 | 18,069 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $887,133 | 17,672 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $686,748 | 17,143 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $776,718 | 20,818 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $807,552 | 20,275 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,076,670 | 28,935 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $1,155,619 | 27,339 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $1,808,501 | 29,633 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $1,047,526 | 22,407 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,195,028 | 23,552 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $747,305 | 16,752 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||